Donate to EWG Today!
Score
Data: Robust
CAS25013-16-5
eye shadow (62 products)
lipstick (60 products)
lip liner (26 products)
mascara (18 products)
facial moisturizer/ treatment (17 products)
Show all 287 products that contain BHA.
how to read the score

Get The Guide!


Want a free Cosmetics Guide? Donate $5 to EWG today!

BHA


image source: PubChem
Health concerns of ingredient
About the ratings
Canceryes
Developmental & reproductive toxicity no information
Allergies & immunotoxicityyes
Use restrictionsyes
Contamination concerns: none
Other HIGH concerns: Organ system toxicity (non-reproductive)
Other MODERATE concerns: Endocrine disruption, Persistence and bioaccumulation
Other LOW concerns: Ecotoxicology, Data gaps

About the ratings

EWG provides information on personal care product ingredients from the published scientific literature, to supplement incomplete data available from companies and the government. The ratings below indicate the relative level of concern posed by exposure to the ingredients in this product - not the product itself - compared to other product formulations. The ratings reflect potential health hazards but do not account for the level of exposure or individual susceptibility, factors which determine actual health risks, if any. Learn more | Legal Disclaimer

Function/use(s): Antioxidant; Fragrance Ingredient; MASKING

About BHA: BHA (butylated hydroxyanisole) is a preservative and stabilizer; U.S. National Toxicology Program, a part of the National Institutes of Health, has classified BHA as "reasonably anticipated to be ... read more

Synonym(s): ANTIOXYNE B; ANTRANCINE 12; EEC NO. E320; EMBANOX; NIPANTIOX 1-F; PROTEX; SUSTANE 1-F; TENOX BHA

Allergies/immunotoxicity

type of concern product conditions reference
Known human immune system toxicant    National Library of Medicine HazMap

Use restrictions

type of concern product conditions reference
Violation of government restrictions - Banned or found unsafe for use in cosmetics   EU Banned and Restricted Fragrances

Endocrine disruption

type of concern product conditions reference
Human endocrine disruptor - strong evidence    European Commission on Endocrine Disruption
One or more studies show significant wildlife and the environment disruption    European Commission on Endocrine Disruption
show more

Cancer

type of concern product conditions reference
Possible human carcinogen products for use on the lips  California EPA Proposition 65
Possible human carcinogen products for use on the lips  NTP Report on Carcinogens, 11th Edition
Possible carcinogen    Environment Canada Domestic Substance List
Limited evidence of carcinogenicity products for use on the lips  Int'l Agency for Research on Cancer (IARC) - Carcinogens

Organ system toxicity (non-reproductive)

type of concern product conditions reference
Known human toxicant    EU Banned and Restricted Fragrances
Classified as a high human health priority    Environment Canada Domestic Substance List
show more

Persistence and bioaccumulation

type of concern product conditions reference
Persistent, bioaccumulative in wildlife    OSPAR PBTs - Substances of Possible Concern
show more

Ecotoxicology

type of concern product conditions reference
Wildlife and environmental toxicity    Illinois EPA Chemicals Associated with Endocrine System
show more

Multiple, additive exposure sources

type of concern product conditions reference
Designated as safe for general or specific, limited use in food   FDA Food Additive Status
Designated as safe for general or specific, limited use in food   FDA Everything Added to Food

Data gaps

type of concern product conditions reference
Risk assessment method deficiencies and data gaps - Maximum reported "as used" concentration is basis of safety assessment by industry safety panel (Cosmetic Ingredient Review, CIR) - implicit safe concentration limit in product   Cosmetic Ingredient Review Assessments
1,946 studies in PubMed science library may include information on the toxicity of this chemical see search results ->   PubMed

Government, industry, academic studies and classifications

government/industry list/academic study appears on list as classification(s)
FDA Food Additive StatusBHA• AOX/FS
• GRAS
• 0.02% - Of fat or oil content
• incl essential (volatile) oil
• or food
• incl oleomargarine - Part 166
• Margarine
• AOX
• REG
• 10 ppm
• alone or w/BHT - In potato granules - CFR172.110
• 32 ppm - In mixed diced
• glazed fruits - CFR172.110
• 50 ppm
• alone
Cosmetic Ingredient Review AssessmentsBHAQQQ01,QQQ11; C-, D-
Cosmetic Ingredient Review AssessmentsBUTYLATED HYDROXYANISOLEQQQ01,QQQ11; C-, D-
FDA Everything Added to FoodBUTYLATED HYDROXYANISOLE• ASP
Environment Canada Domestic Substance ListPHENOL, (1,1-DIMETHYLETHYL)-4-METHOXY-,,High-Health Priority,,,,Carcinogenic,,,
Illinois EPA Chemicals Associated with Endocrine SystemTERT-BUTYLHYDROXYANISOLEEPA: Suspected Endocrine Disruptor
European Commission on Endocrine DisruptionTERT.-BUTYLHYDROXYANISOLE (BHA)HH-CAT1;WF-CAT1
EU Banned and Restricted FragrancesBHAProhibited. Should not be used as a fragrance ingredient. Based on the depigmenting effect (pc to IFRA).
IFRA Fragrance Ingredient ListPHENOL, (1,1-DIMETHYLETHYL)-4-METHOXY-reported as used in fragrance compounds in 2008
National Library of Medicine HazMapBUTYLATED HYDROXYANISOLESS: Yes;
Int'l Agency for Research on Cancer (IARC) - CarcinogensBUTYLATED HYDROXYANISOLE (BHA)IARC GROUP 2B
NTP Report on Carcinogens, 11th EditionBUTYLATED HYDROXYANISOLE (BHA)Reasonably Anticipated to be a Human Carcinogen
Our Stolen Future Endocrine DisruptorsBUTYLATED HYDROXYANISOLE (BHA)Estrogen
OSPAR PBTs - Substances of Possible Concern(1,1DIMETHYLETHYL)4METHOXYPHENOLChemical of Concern under the OSPAR convention
California EPA Proposition 65BUTYLATED HYDROXYANISOLEcancer
Japanese National Institute of Health Sciences, 1993BUTYLATED HYDROXYANISOLE (BHA)Endocrine Toxicity Hazards: suspected

Other RTECS® classifications [shown for informational purposes only]

government/industry list/academic study appears on list as classification(s)
RTECS®- Australian Journal of Experimental Biology and Medical Science 1959BHA• liver - Changes in liver weight (rat TDLo)
RTECS®- Australian Journal of Experimental Biology and Medical Science 1961BHA• endocrine system - Changes in adrenal weight (rat TDLo)
• blood - Changes in serum composition (eg., TP, bilirubin, cholesterol) (rat TDLo)
RTECS®- British Journal of Cancer 1982BHA• liver - Changes in liver weight (mouse TDLo)
• biochemical - Hepatic microsomal mixed oxidase (dealkylation, hydroxylation, etc.) (mouse TDLo)
• liver - Other changes (mouse TDLo)
RTECS®- Bulletin of Environmental Contamination and Toxicology 1985BHA• biochemical - Hepatic microsomal mixed oxidase (dealkylation, hydroxylation, etc.) (rat TDLo)
• liver - Other changes (rat TDLo)
RTECS®- Cancer Letters (Shannon, Ireland) 1986BHA• mutagenic - Positive mutation assay: Unscheduled DNA Synthesis (rat orl)
RTECS®- Cancer Letters (Shannon, Ireland) 1999BHA• cancer - Active as anti-cancer agent (mouse TDLo)
• cancer - Protects against induction of experimental tumors (mouse TDLo)
• respiratory - Tumors (mouse TDLo)
RTECS®- Cancer Letters (Shannon, Ireland) 1999BHA• cancer - Active as anti-cancer agent (rat TDLo)
• cancer - Protects against induction of experimental tumors (rat TDLo)
• liver - Tumors (rat TDLo)
RTECS®- Cancer Letters (Shannon, Ireland) 1986BHA• mutagenic - Positive mutation assay: Unscheduled DNA Synthesis (rat orl)
RTECS®- Cancer Research 1986BHA• cancer - respiratory neoplasms (rat TD)
RTECS®- Carcinogenesis (London) 1992BHA• mutagenic - Positive mutation assay: DNA Inhibition ( human hla)
RTECS®- Carcinogenesis (London) 1983BHA• cancer - Cells (cultured) transformed (rat TD)
• cancer - kidney or renal system tumors (rat TD)
RTECS®- Carcinogenesis (London) 1992BHA• mutagenic - Positive mutation assay: DNA Inhibition ( human hla)
RTECS®- Federation Proceedings, Federation of American Societies for Experimental Biology 1972BHA• reproductive - Behavioral (mouse TDLo)
RTECS®- FEMS Microbiology Letters 1982BHA• mutagenic - Positive mutation assay: Mutation in Micro-organism (other micro-organisms )
RTECS®- FEMS Microbiology Letters 1982BHA• mutagenic - Positive mutation assay: Mutation in Micro-organism (other micro-organisms )
RTECS®- Food and Chemical Toxicology 1986BHA• liver - Changes in liver weight (monkey TDLo)
• gastrointestinal - Other changes (monkey TDLo)
• biochemical - Other enzymes (monkey TDLo)
RTECS®- Food and Chemical Toxicology 2004BHA• liver - Changes in liver weight (rat TDLo)
• biochemical - Hepatic microsomal mixed oxidase (dealkylation, hydroxylation, etc.) (rat TDLo)
• liver - Other changes (rat TDLo)
RTECS®- Food and Cosmetics Toxicology 1972BHA• liver - Changes in liver weight (monkey TDLo)
• liver - Other changes (monkey TDLo)
• biochemical - Phosphatases (monkey TDLo)
RTECS®- Food and Cosmetics Toxicology 1965BHA• liver - Changes in liver weight (rat TDLo)
• biochemical - Phosphatases (rat TDLo)
RTECS®- Gann 1982BHA• cancer - gastrointestinal tumor formations - equivocal (rat TD)
• cancer - gastrointestinal tumors (rat TDLo)
RTECS®- Gann 1983BHA• cancer - gastrointestinal neoplasms (hamster TD)
RTECS®- Japanese Journal of Cancer Research 1986BHA• cancer - gastrointestinal tumor formations - equivocal (mouse TDLo)
• cancer - gastrointestinal tumors (hamster TDLo)
RTECS®- Japanese Journal of Cancer Research 1986BHA• cancer - gastrointestinal neoplasms (rat TD)
RTECS®- Japanese Journal of Cancer Research 1993BHA• mutagenic - endocrine system tumors (rat TD)
• cancer - gastrointestinal tumors (rat TD)
RTECS®- Journal of the American Oil Chemists' Society 1977BHA• broad systemic - Broad systemic toxicity (rabbit LD50)
RTECS®- Journal of the National Cancer Institute 1977BHA• mutagenic - Positive mutation assay: Sister Chromatid Exchange (hamster fbr)
RTECS®- Journal of the National Cancer Institute 1977BHA• mutagenic - Positive mutation assay: Sister Chromatid Exchange (hamster fbr)
RTECS®- Kenkyu Nenpo--Tokyo-toritsu Eisei Kenkyusho 1970BHA• brain, nervous system, or behavioral effect - Altered sleep time (including change in righting reflex) (mouse LD50)
• brain, nervous system, or behavioral effect - Ataxia (mouse LD50)
• liver - Changes in liver weight (rat TDLo)
• blood - Changes in serum composition (eg., TP, bilirubin, cholesterol) (rat TDLo)
• endocrine system - Changes in thyroid weight (rat TDLo)
• respiratory - Respiratory stimulation (mouse LD50)
RTECS®- Mutation Research 1996BHA• mutagenic - Positive mutation assay: DNA Damage (rat lvr)
RTECS®- Mutation Research 2002BHA• mutagenic - Positive mutation assay: DNA Damage (mouse orl)
RTECS®- Mutation Research 1996BHA• mutagenic - Positive mutation assay: DNA Damage (rat lvr)
RTECS®- Mutation Research 2002BHA• mutagenic - Positive mutation assay: DNA Damage (mouse orl)
RTECS®- Neurobehavioral Toxicology and Teratology 1981BHA• reproductive - Growth statistics (rat TDLo)
• reproductive - Weaning or lactation index (rat TDLo)
RTECS®- Toxicology and Applied Pharmacology 2004BHA• reproductive - Uterus, cervix, vagina (rat TDLo)
• endocrine system - Changes in adrenal weight (rat TDLo)
• liver - Changes in liver weight (rat TDLo)
• endocrine system - Changes in prostate weight (rat TDLo)
• endocrine system - Changes in uterine weight (rat TDLo)
RTECS®- Toxicology In Vitro 1991BHA• mutagenic - Positive mutation assay: DNA Inhibition (hamster lng)
RTECS®- Toxicology In Vitro 1991BHA• mutagenic - Positive mutation assay: DNA Inhibition (hamster lng)
RTECS®- Toxicology Letters 2003BHA• biochemical - Hepatic microsomal mixed oxidase (dealkylation, hydroxylation, etc.) (rat TDLo)
• biochemical - Other transferases (rat TDLo)
RTECS®- Toxicology Letters 1985BHA• blood - Hemorrhage (rat LD50)
• metabolic - Weight loss or decreased weight gain (rat TDLo)
• respiratory - Changes in lung weight (rat TDLo)
• blood - Other hemolysis with or without anemia (rat TDLo)
RTECS®- Toxicology Letters 1986BHA• cancer - gastrointestinal tumors (rat TD)
RTECS®- Toxicology 2005BHA• developmental - Delayed effects (rat TDLo)
• reproductive - Mating performance (rat TDLo)
• reproductive - Other effects in male (rat TDLo)

references

government/industry list/academic study reference
FDA Food Additive StatusFDA (U.S. Food and Drug Administration) 2006. Food Additive Status List. Downloaded from http://www.cfsan.fda.gov/%7Edms/opa-appa.html, Oct 16, 2006.
Cosmetic Ingredient Review AssessmentsCIR (Cosmetic Ingredient Review). 2006. CIR Compendium, containing abstracts, discussions, and conclusions of CIR cosmetic ingredient safety assessments. Washington DC.
FDA Everything Added to FoodFDA (U.S. Food and Drug Administration). 2008. EAFUS [Everything Added to Food]: A Food Additive Database. FDA Office of Food Safety and Applied Nutrition.
Environment Canada Domestic Substance ListEC (Environment Canada). 2008. Domestic Substances List Categorization. Canadian Environmental Protection Act (CEPA) Environmental Registry.
Illinois EPA Chemicals Associated with Endocrine SystemIllinois EPA (Illinois Environmental Protection Agency). 2000. Preliminary list of chemicals associated with endocrine system effects in animals and humans (*) or in vitro (+). In EPA (U.S. Environmental Protection Agency) 2000. Handbook for Non-Cancer Health Effects Valuation, Appendix C.
European Commission on Endocrine DisruptionEU (European Union)- Strategy for Endocrine Disrupters 2007. Commision on endocrin disruption requested by the European Parliament in 1998.
EU Banned and Restricted FragrancesSCCPNFP (Scientific Committee On Cosmetic Products And Non-Food Products). 1999. Opinion Concerning Fragrance Allergy In Consumers. . SCCNFP/0017/98 Final, December 1999; and SCCPNFP (Scientific Committee On Cosmetic Products And Non-Food Products). 2000. An Initial List Of Perfumery Materials Which Must Not Form Part Of Fragrances Compounds Used In Cosmetic Products. SCCNFP/0320/00, final May 2000.
IFRA Fragrance Ingredient ListIFRA (International Fragrance Assocication). 2010. IFRA Fragrance Ingredient List based on 2008 Use Survey. Accessed online 01/04/2010: http://www.ifraorg.org/Home/News/Latest-News/page.aspx/66?xf_itemId=43&xf_selectionDatapartId=25
National Library of Medicine HazMapNLM (National Library of Medicine). 2006. HazMap — Occupational Exposure to Hazardous Agents.
Int'l Agency for Research on Cancer (IARC) - CarcinogensIARC (International Agency for Research on Cancer). 2008. Overall Evaluations of Carcinogenicity to Humans, as evaluated in IARC Monographs Volumes 1-99 (a total of 935 agents, mixtures and exposures).
NTP Report on Carcinogens, 11th EditionNTP (National Toxicology Program). 2005. Report on Carcinogens, Eleventh Edition; U.S. Department of Health and Human Services, Public Health Service, National Toxicology Program.
Our Stolen Future Endocrine DisruptorsColborn T, D Dumanoski, JP Myers. 2006. Widespread Pollutants with Endocrine-disrupting Effects. Updated from original listing in "Our Stolen Future" (1996).
OSPAR PBTs - Substances of Possible ConcernOSPAR (Oslo-Paris). 2002. OSPAR List of Substances of Possible Concern. Secondary OSPAR List of Substances of Possible Concern. Secondary OSPAR. Place Published, OSPAR Convention for the Protection of the Marine Environement of North-East Atlanic.
California EPA Proposition 65California EPA (California Environmental Protection Agency). 9/2008. Office of Environmental Health Hazard Assessment. Safe Drinking Water and Toxic Enforcement Act of 1986. Chemicals known to the State to cause cancer or reproductive toxicity.
Scorecard.org Toxicity InformationJapanese National Institute of Health Sciences. Lists of Paradigmatic Chemicals. http://www.nihs.go.jp/hse/endocrine-e/paradigm/paradigm.html, World Wildlife Fund. Our Stolen Future. Widespread Pollutants with Endocrine-disrupting Effects. http://www.ourstolenfuture.org/Basics/chemlist.htm. The WWF list is derived from references detailed at http://www.ourstolenfuture.org/Sources/chemsources.htm and was originally published in: Colborn, T., F.S. vom Saal, and A.M. Soto. Developmental Effects of Endocrine-Disrupting Chemicals In Wildlife and Humans. Environmental Health Perspectives 101(5): 378-384. 1993.
RTECS®- Australian Journal of Experimental Biology and Medical Science 1959 [shown for informational purposes only]RTECS®- Australian Journal of Experimental Biology and Medical Science. (Adelaide, S.A., Australia) V.1-64, 1924-86. 37,533,1959
RTECS®- Australian Journal of Experimental Biology and Medical Science 1961 [shown for informational purposes only]RTECS®- Australian Journal of Experimental Biology and Medical Science. (Adelaide, S.A., Australia) V.1-64, 1924-86. 39,353,1961
RTECS®- British Journal of Cancer 1982 [shown for informational purposes only]RTECS®- British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- 45,935,1982
RTECS®- Bulletin of Environmental Contamination and Toxicology 1985 [shown for informational purposes only]RTECS®- Bulletin of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1966- 34,787,1985
RTECS®- Cancer Letters (Shannon, Ireland) 1986 [shown for informational purposes only]RTECS®- Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 33,119,1986
RTECS®- Cancer Letters (Shannon, Ireland) 1999 [shown for informational purposes only]RTECS®- Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- 137,123,1999
RTECS®- Cancer Letters (Shannon, Ireland) 1999 [shown for informational purposes only]RTECS®- Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- 143,173,1999
RTECS®- Cancer Letters (Shannon, Ireland) 1986 [shown for informational purposes only]RTECS®- Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- 33,119,1986
RTECS®- Cancer Research 1986 [shown for informational purposes only]RTECS®- Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- 46,165,1986
RTECS®- Carcinogenesis (London) 1992 [shown for informational purposes only]RTECS®- Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- 13,2389,1992
RTECS®- Carcinogenesis (London) 1983 [shown for informational purposes only]RTECS®- Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- 4,895,1983
RTECS®- Carcinogenesis (London) 1992 [shown for informational purposes only]RTECS®- Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 13,2389,1992
RTECS®- Federation Proceedings, Federation of American Societies for Experimental Biology 1972 [shown for informational purposes only]RTECS®- Federation Proceedings, Federation of American Societies for Experimental Biology. (Bethesda, MD) V.1-46, 1942-87. 31,596,1972
RTECS®- FEMS Microbiology Letters 1982 [shown for informational purposes only]RTECS®- FEMS Microbiology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- 14,183,1982
RTECS®- FEMS Microbiology Letters 1982 [shown for informational purposes only]RTECS®- FEMS Microbiology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 14,183,1982
RTECS®- Food and Chemical Toxicology 1986 [shown for informational purposes only]RTECS®- Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- 24,1197,1986
RTECS®- Food and Chemical Toxicology 2004 [shown for informational purposes only]RTECS®- Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- 42,899,2004
RTECS®- Food and Cosmetics Toxicology 1972 [shown for informational purposes only]RTECS®- Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. 10,769,1972
RTECS®- Food and Cosmetics Toxicology 1965 [shown for informational purposes only]RTECS®- Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. 3,457,1965
RTECS®- Gann 1982 [shown for informational purposes only]RTECS®- Gann. Japanese Journal of Cancer Research. (Tokyo, Japan) V.1-75, 1907-84. For publisher information, see JJCREP. 73,332,1982
RTECS®- Gann 1983 [shown for informational purposes only]RTECS®- Gann. Japanese Journal of Cancer Research. (Tokyo, Japan) V.1-75, 1907-84. For publisher information, see JJCREP. 74,459,1983
RTECS®- Japanese Journal of Cancer Research 1986 [shown for informational purposes only]RTECS®- Japanese Journal of Cancer Research. (Elsevier Science Pub. BV, POB 211, 1000 AE Amsterdam, Netherlands) V.76- 1985- 77,1083,1986
RTECS®- Japanese Journal of Cancer Research 1986 [shown for informational purposes only]RTECS®- Japanese Journal of Cancer Research. (Elsevier Science Pub. BV, POB 211, 1000 AE Amsterdam, Netherlands) V.76- 1985- 77,854,1986
RTECS®- Japanese Journal of Cancer Research 1993 [shown for informational purposes only]RTECS®- Japanese Journal of Cancer Research. (Elsevier Science Pub. BV, POB 211, 1000 AE Amsterdam, Netherlands) V.76- 1985- 84,237,1993
RTECS®- Journal of the American Oil Chemists' Society 1977 [shown for informational purposes only]RTECS®- Journal of the American Oil Chemists' Society. (Champaign, IL) V.24-56, 1947-79. 54,239,1977
RTECS®- Journal of the National Cancer Institute 1977 [shown for informational purposes only]RTECS®- Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. 58,1635,1977
RTECS®- Journal of the National Cancer Institute 1977 [shown for informational purposes only]RTECS®- Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. 58,1635,1977
RTECS®- Kenkyu Nenpo--Tokyo-toritsu Eisei Kenkyusho 1970 [shown for informational purposes only]RTECS®- Kenkyu Nenpo--Tokyo-toritsu Eisei Kenkyusho. Annual Report of Tokyo Metropolitan Research Laboratory of Public Health. (Tokyo-toritsu Eisei Kenkyusho, 24-1, 3-chome, Hyakunin-cho, Shin-juku-ku, Tokyo 160, Japan) V.1- 1949/50- 22,231,1970
RTECS®- Mutation Research 1996 [shown for informational purposes only]RTECS®- Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 368,59,1996
RTECS®- Mutation Research 2002 [shown for informational purposes only]RTECS®- Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 519,103,2002
RTECS®- Mutation Research 1996 [shown for informational purposes only]RTECS®- Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- -1964 368,59,1996
RTECS®- Mutation Research 2002 [shown for informational purposes only]RTECS®- Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- -1964 519,103,2002
RTECS®- Neurobehavioral Toxicology and Teratology 1981 [shown for informational purposes only]RTECS®- Neurobehavioral Toxicology and Teratology. (Fayetteville, NY) V.3-8, 1981-86. For publisher information, see NETEEC. 3,321,1981
RTECS®- Toxicology and Applied Pharmacology 2004 [shown for informational purposes only]RTECS®- Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- 197,230,2004
RTECS®- Toxicology In Vitro 1991 [shown for informational purposes only]RTECS®- Toxicology In Vitro. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 5,549,1991
RTECS®- Toxicology In Vitro 1991 [shown for informational purposes only]RTECS®- Toxicology In Vitro. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- 5,549,1991
RTECS®- Toxicology Letters 2003 [shown for informational purposes only]RTECS®- Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- 145,281,2003
RTECS®- Toxicology Letters 1985 [shown for informational purposes only]RTECS®- Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- 27,15,1985
RTECS®- Toxicology Letters 1986 [shown for informational purposes only]RTECS®- Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- 31(Suppl),207,1986
RTECS®- Toxicology 2005 [shown for informational purposes only]RTECS®- Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- 208,49,2005

"RTECS®" is a United States trademark owned and licensed under authority of the U.S. Government, by and through MDL Information Systems, Inc.